Value-based insurance design copayment reductions sustained medication adherence 2 years into policy implementation and were most effective in patients with poor adherence before policy implementation.
Daryl Wansink, PhD
Advertisement
Articles by Daryl Wansink, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies
2
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
3
CMS Proposes Permanent Rules for Medicare Drug Price Negotiation
4
AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike
5